Study of Liver Transplant For End-Stage Liver Disease Caused By Chronic Hepatitis C Infection
Status:
Completed
Trial end date:
2007-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare three treatment regimens in patients who have
received a liver transplant for end-stage liver disease caused by Chronic Hepatitis C
infection.
Phase:
Phase 4
Details
Lead Sponsor:
Baylor Research Institute
Collaborators:
Baylor Health Care System Baylor University Emory University Lahey Clinic Mayo Clinic Mayo Clinic - Rochester, Minnesota Mayo Clinic - Scottsdale/Phoenix, Arizona Medical University of South Carolina New York Presbyterian Hospital New York University Northwestern Memorial Hospital Oregon Health and Science University The University of Texas Health Science Center at San Antonio University of Alabama at Birmingham University of California, San Francisco University of Chicago University of Cincinnati University of Medicine and Dentistry of New Jersey University of Southern California University of Texas University of Virginia